OPRK1 and early-onset autosomal dominant Alzheimer disease: Depending on the selectivity of salvinorin A for the opioid kappa receptor, this receptor constitutes a potential molecular target for the development of pharmaceuticals used for the study of characteristic features of different perception disorders, including schisophrenia, the Alzheimer's disease and bipolar affective disorder36.